MedTrace Logo

Health Effects of Oat Bioactives (Betaglucan) in Human

NCT05801653 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2023-10-04

No results posted yet for this study

Summary

Aim of the study is to investigate health effects of oats and oat derived components, in human intervention studies, with the purpose to build new knowledge for development of cardiometabolic protective foods.

Conditions

  • Healthy

Interventions

DIETARY_SUPPLEMENT

Effects of Oat and Oat Components on Cardiometabolic risk variables

Oat and oat bioactive components consumed as breakfast meal.

Sponsors & Collaborators

  • Swedish Foundation for Strategic Research

    collaborator OTHER

  • Lund University

    lead OTHER

Principal Investigators

  • Anne Nilsson · Department of Food Technology, Engineering and Nutrition, Lund Univesity

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
20 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-03-08
Primary Completion
2023-06-15
Completion
2023-08-10

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05801653 on ClinicalTrials.gov